- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted manuscript
- Files:
-
-
(pdf, 128.8KB)
-
- Publisher copy:
- 10.1093/annonc/mdx440.051
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
- Publisher:
- Oxford University Press Publisher's website
- Volume:
- 28
- Issue:
- suppl_5
- Pages:
- 635-636
- Publication date:
- 2017-09-18
- Acceptance date:
- 2017-07-27
- DOI:
- ISSN:
-
0923-7534 and 1569-8041
- Pubs id:
-
pubs:738403
- URN:
-
uri:a956854d-1faa-47bf-aa60-bcc314b711d6
- UUID:
-
uuid:a956854d-1faa-47bf-aa60-bcc314b711d6
- Local pid:
- pubs:738403
- Copyright holder:
- © European Society for Medical Oncology 2017. Published by Oxford University Press. All rights reserved.
- Copyright date:
- 2017
- Notes:
- This is the author accepted manuscript following peer review version of the article. The final version is available online from Oxford University Press at: 10.1093/annonc/mdx440.051
Conference item
ABOUND.2L+: nab-paclitaxel (nab-P) +/- CC-486 or durvalumab in previously treated patients with advanced non-small cell lung cancer (NSCLC)
Actions
Access Document
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Celgene Corporation
More from this funder
Bibliographic Details
Terms of use
If you are the owner of this record, you can report an update to it here: Report update to this record